DelveInsight projects the global Drug Delivery Devices market to grow at a 7.90% CAGR through 2030, driven by rising chronic diseases and innovation in injectables, inhalers, implants, and patches. Key players include Pfizer, Johnson & Johnson, Roche, Novartis, 3M, Bayer, Boehringer Ingelheim, and Medtronic. Oncology, diabetes, and respiratory diseases fuel demand, with FDA’s QMSR set...